The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

AGIO FINANCIAL STATEMENTS

Agios Pharm — balance sheet, income statement and cash flow trends

AGIOAgios Pharm

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
0500 M202020222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue98.3 M $Gross Profit86.5 M $ · 88%Operating Income-459 M $ · -467%Pre-tax Income-412.3 M $ · -419%Net Income to Owners-411.3 M $ · -418%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue98.3 M $+140.6%
Gross Profit86.5 M $+158.0%
Operating Income-459 M $—
EBITDA-416.8 M $-159.6%
Net Income to Owners-411.3 M $-163.3%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M1 B1.5 B202020222023202420252026

Capital Structure

Q2 2026
Total Assets1.1 B
  • Equity1 B $93%
  • Current Liabilities70.2 M $6%
  • Long-term Liabilities12.2 M $1%

Key Figures

YoY change
Total Assets1.1 B $-24.7%
Total Liabilities82.4 M $-19.0%
Total Equity1 B $-25.1%
Cash & ST Investments617.6 M $-34.2%
Total Debt31.2 M $-36.1%
Net Debt-68.5 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-400 M-200 M0202020222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-200 M0-360.6 M $Operating367.2 M $Investing12.2 M $Financing18.8 M $Net Change

Key Figures

YoY change
Operating Cash Flow-360.6 M $—
Capital Expenditures4.7 M $+53.8%
Free Cash Flow-365.3 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on AGIO

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.